Official Journal of the Italian Society of Orthopaedics and Traumatology
Table 2 Demographics characteristics of the polytherapy per-treatment group and monotherapy per-treatment group
From: Polytherapy versus monotherapy in the treatment of tibial non-unions: a retrospective study
Polytherapy per-treatment (n = 20) | Monotherapy per-treatment (n = 24) | P value | |
|---|---|---|---|
Age (Mean ± SD) (years) | 47.4 ± 14.0 | 52.5 ± 13.3 | 0.223 |
Female (%) | 5 (25%) | 7 (29%) | 0.514 |
BMI (Mean ± SD) (weight (kg)/height (m)2) | 25.0 ± 4.0 | 27.3 ± 5.7 | 0.135 |
NUSS (M (P25, P75))b | 48 (43, 60) | 38 (30, 50) | 0.030 (z = −2.173)* |
High-energy trauma cases (%) | 11 (55%) | 6 (25%) | 0.063 |
Fracture type (0: I: II: IIIA: IIIB: IIIC)a | 7:2:5:3:3:0 | 14:1:5:1:3:0 | 0.170 (z = −1.372) |
Fixation (Intramedullary nail: Plate: conservative)c | 8:7:5 | 8:13:3 | 0.878 (z = −0.153) |
Isolated fracture (%) | 16 (80%) | 20 (83%) | 1.000 |
Smoking status (%) | 7 (35%) | 4 (17%) | 0.185 |
Hypertension (%) | 0 (0%) | 1 (4%) | 1.000 |
Diabetes mellitus (%) | 2 (10%) | 1 (4%) | 0.538 |
Hypercholesterolaemia (%) | 1 (5%) | 4 (17%) | 0.356 |
Respiratory disease (%) | 3 (15%) | 6 (25%) | 0.477 |
Congestive heart failure (%) | 2 (10%) | 3 (13%) | 1.000 |
Coronary artery disease (%) | 2 (10%) | 2 (8%) | 1.000 |
Prior cerebrovascular event (%) | 0 (0%) | 1 (4%) | 1.000 |
Liver disease (%) | 0 (0%) | 0 (0%) | NAb |
Cancer history in other systems (%) | 2 (10%) | 0 (0%) | 0.201 |
Peripheral vascular disease (%) | 1 (5%) | 3 (13%) | 0.614 |